Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

11 treatments under study, led by Amino Acid Intake

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 8 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 8 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

8Total
Not Applicable (7)
Early Phase 1 (1)

Trial Status

Completed8

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 8 completed trials

Clinical Trials (8)

Research Network

Common Treatments

  • Amino Acid Intake5
  • Bcaaenriched Egg Protein1
  • Essential Amino Acids1
  • Large Amount Of Essential Amino Acids1
  • Amino Acids Intake1

Active Sponsors

  • University of Toronto7
  • Ajinomoto Co., Inc.6
  • Daniel Moore1

Top Investigators

Related Conditions

  • Healthy8

Activity Timeline